IDEAYA Biosciences, Inc.
NASDAQIDEAYA Biosciences heads into its May 6 earnings release with a noteworthy split between short sellers building exposure and options traders positioned for upside rather than protection. Short interest has climbed sharply. It rose nearly 14% over the past month to just under 12% of the free float — roughly 10.5 million shares — with most of that build concentrated in the final week…
Snapshot as of 9 May 2026
IDEAYA Biosciences heads into its May 6 earnings release with a noteworthy split between short sellers building exposure and options traders positioned for upside rather than protection. Short interest has climbed…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for IDYA — free to start on ORTEX.
Sign up for free →Open IDYA on ORTEX